Incheon, South Korea

Choong Leol Yoo

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chong Kun Dang Pharmaceutical Corporation. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Choong Leol Yoo. Retrieved from https://idiyas.com/inventor/choong-leol-yoo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Choong Leol Yoo

Introduction

Choong Leol Yoo is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of atorvastatin, a medication used to lower cholesterol levels.

Latest Patents

Yoo holds a patent for a novel method for the preparation of atorvastatin and the intermediates used therein. This invention relates to a safe and efficient method for producing large amounts of atorvastatin, utilizing a unique intermediate that enhances the preparation process.

Career Highlights

Choong Leol Yoo is associated with Chong Kun Dang Pharmaceutical Corporation, where he has been instrumental in advancing pharmaceutical innovations. His work has not only contributed to the company's portfolio but has also had a positive impact on public health.

Collaborations

Yoo has collaborated with notable colleagues, including Soon Kil Ahn and Hong-Woo Lee, to further enhance the research and development efforts within the pharmaceutical sector.

Conclusion

Choong Leol Yoo's innovative approach to the preparation of atorvastatin exemplifies the importance of research and development in the pharmaceutical industry. His contributions continue to influence the field and improve health outcomes for many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…